Express News | Delta Plus: MidCap Partners Cuts Target Price to EUR 74 From EUR 78; Rating "Buy"

ReutersFeb 14 03:01 ET

Further Weakness as Autolus Therapeutics (NASDAQ:AUTL) Drops 9.0% This Week, Taking Five-year Losses to 83%

Simply Wall StFeb 11 05:37 ET

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT NewswiresJan 23 11:27 ET

Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating

Moomoo NewsJan 23 07:33 ET · Ratings

Autolus Therapeutics (AUTL) Gets a Buy From Truist Financial

TipRanksJan 23 07:26 ET · Ratings

Express News | Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes

BenzingaJan 17 07:12 ET